Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin

Department of Family and Preventive Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Journal of the American Academy of Dermatology (Impact Factor: 4.45). 11/2011; 65(5 Suppl 1):S69-77. DOI: 10.1016/j.jaad.2011.04.033
Source: PubMed


An estimated 750,000 melanoma survivors in the United States are at increased risk of subsequent primary cancers.
We sought to assess the risk of developing subsequent primary cancers among people with cutaneous melanoma.
Using 1992 to 2006 data from the National Cancer Institute Surveillance, Epidemiology, and End Results Program, 40,881 people with in situ melanoma and 76,041 people with invasive melanoma were followed up (mean of 5.6 years) for the development of subsequent primary cancers. The observed number of subsequent cancers was compared with those expected based on age-/race-/year-/site-specific rates in the Surveillance, Epidemiology, and End Results population. Standardized incidence ratios (SIRs) (SIR = observed number/expected number) were considered statistically significant if they differed from 1, with an alpha level of 0.05.
After a first primary in situ melanoma, risk was significantly elevated for subsequent invasive melanoma and chronic lymphocytic leukemia among men (SIRs = 8.43 and 1.44, respectively) and women (SIRs = 12.33 and 1.79, respectively). After a first primary invasive melanoma, risk was significantly elevated for subsequent invasive melanoma, thyroid cancer, non-Hodgkin lymphoma, and chronic lymphocytic leukemia among both men (SIRs = 12.50, 2.67, 1.56, and 1.57, respectively) and women (SIRs = 15.67, 1.77, 1.42, and 1.63, respectively).
Case ascertainment issues particularly affecting in situ melanoma cases could affect results. The role of detection bias in the diagnoses of some subsequent cancers cannot be completely eliminated.
The findings of the study should guide the development of strategies such as posttreatment surveillance, screening, and ultraviolet exposure education among melanoma survivors to improve cancer survivorship.

Download full-text


Available from: Appathurai Balamurugan, Dec 16, 2013
18 Reads
  • Source
    • "The risk of thyroid cancer was significantly increased, both after an initial CMM (both sexes) and SCC (women only), also consistent with previous findings [11,21,25-27,31]. Common risk factors such as genetic or environmental exposure have been suggested to explain this association [25]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Skin cancer survivors experience an increased risk for subsequent malignancies but the associated risk factors are poorly understood. This study examined the risk of a new primary cancer following an initial skin cancer and assessed risk factors associated with second primary cancers. All invasive cutaneous malignant melanomas (CMM, N = 28 069) and squamous cell carcinomas (SCC, N = 24 620) diagnosed in Norway during 1955-2008 were included. Rates of new primary cancers in skin cancer survivors were compared to rates of primary malignancies in the general population using standardized incidence ratios (SIR). Discrete-time logistic regression models were applied to individual-level data to estimate cancer risk among those with and without a prior skin cancer, accounting for residential region, education, income, parenthood, marital status and parental cancer status, using a 20% random sample of the entire Norwegian population as reference. Further analyses of the skin cancer cohort were undertaken to determine risk factors related to subsequent cancers. During follow-up, 9608 new primary cancers occurred after an initial skin cancer. SIR analyses showed 50% and 90% increased risks for any cancer after CMM and SCC, respectively (p < 0.01). The logistic regression model suggested even stronger increase after SCC (130%). The highest risk was seen for subsequent skin cancers, but several non-skin cancers were also diagnosed in excess: oral, lung, colon, breast, prostate, thyroid, leukemia, lymphoma and central nervous system. Factors that were associated with increased risk of subsequent cancers include male sex, older age, lower residential latitude, being married and low education and income. Parental cancer did not increase the risk of a subsequent cancer after SCC, but was a significant predictor among younger CMM survivors. Our results provide information on shared environmental and genetic risk factors for first and later cancers and may help to identify individuals at high risk for subsequent cancers, which will be important as skin cancer incidence continues to rise.
    BMC Cancer 03/2014; 14(1):210. DOI:10.1186/1471-2407-14-210 · 3.36 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Skin cancer is the most common form of cancer in the United States. Melanoma skin cancer is particularly deadly; more than 8000 US residents die from it each year. Although recent reports suggest that melanoma incidence rates have been increasing, these apparent increases could be caused by an increase in reporting and/or screening, and by an actual increase in the occurrence of melanoma. In this report, we describe methods used in this supplement to assess the current burden of melanoma in the United States using data from two federal cancer surveillance programs: the Centers for Disease Control and Prevention (CDC) National Program of Cancer Registries and the National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results program. We also provide basic descriptive epidemiologic data about melanoma in the United States. Cancer incidence data from population-based cancer registries that participate in the CDC National Program of Cancer Registries and/or the NCI Surveillance, Epidemiology, and End Results Program covering 78% of the US population for 2004 to 2006 were used. Over 45 thousand melanomas were diagnosed annually, with a rate of 19 cases per 100,000 persons. Melanoma rates may vary because of differences in reporting, diagnosis, and screening. To our knowledge, the articles in this supplement constitute the first comprehensive examination of the overall burden of melanoma in the United States based on data from a majority of the US population.
    Journal of the American Academy of Dermatology 11/2011; 65(5 Suppl 1):S6-16. DOI:10.1016/j.jaad.2011.04.037 · 4.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cutaneous melanoma continues to be a public health problem worldwide and its incidence continues to increase around the globe. The recognition of melanoma risk factors allows for the identification of a subgroup of high-risk patients that will likely benefit most from approaches aimed at minimizing exposure to ultraviolet radiation and from surveillance strategies geared towards finding melanomas while thin and easily curable. Herein, we will provide an overview of the most pertinent, novel and newly described melanoma risk factors and melanoma prognostic factors. The potential benefits of skin cancer surveillance strategies including physician-based total body skin examination, total body photography, dermoscopy and patient-based self-skin examination will be examined. In addition, management of melanoma patients, focusing on prevention and early detection strategies will be discussed.
    Giornale Italiano di Dermatologia e Venereologia 02/2012; 147(1):1-19. · 0.68 Impact Factor
Show more